Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Conway DS"'
Autor:
Abbatemarco, JR, Aboseif, A, Swetlik, C, Widmar, J, Harvey, T, Kunchok, A, O'Mahony, J, Miller, DM, Conway, DS
Publikováno v:
Multiple Sclerosis Journal; Sep2024, Vol. 30 Issue 10, p1322-1330, 9p
Autor:
Conway Ds, Gregory Y.H. Lip
Publikováno v:
Therapy. 1:111-121
Atrial fibrillation (AF) is the most common sustained arrhythmia encountered in clinical practice, with an incidence that increases twofold every decade after 55 years of age. Despite recent advances in our understanding of the mechanisms of AF, effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7068720856b792ed9b353d975dd53a8
https://doi.org/10.2217/14750708.1.1.111
https://doi.org/10.2217/14750708.1.1.111
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
James SD; Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea, UK. m.r.gill@swansea.ac.uk., Elgar CE; Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea, UK. m.r.gill@swansea.ac.uk., Chen D; State Key Laboratory of Biotherapy, Department of Radiology and National Clinical Research Center for Geriatrics, Huaxi MR Research Center (HMRRC), Frontiers Science Center for Disease-Related Molecular Network, West China Hospital of Sichuan University, Sichuan University, Chengdu 610000, Sichuan Province, China. xiaohe.t@wchscu.cn., Lewis MI; Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea, UK. m.r.gill@swansea.ac.uk., Ash ETL; Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea, UK. m.r.gill@swansea.ac.uk., Conway DS; Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea, UK. m.r.gill@swansea.ac.uk., Tuckley BJ; Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea, UK. m.r.gill@swansea.ac.uk., Phillips LE; Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea, UK. m.r.gill@swansea.ac.uk., Kolozsvári N; Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea, UK. m.r.gill@swansea.ac.uk., Tian X; State Key Laboratory of Biotherapy, Department of Radiology and National Clinical Research Center for Geriatrics, Huaxi MR Research Center (HMRRC), Frontiers Science Center for Disease-Related Molecular Network, West China Hospital of Sichuan University, Sichuan University, Chengdu 610000, Sichuan Province, China. xiaohe.t@wchscu.cn., Gill MR; Department of Chemistry, Faculty of Science and Engineering, Swansea University, Swansea, UK. m.r.gill@swansea.ac.uk.
Publikováno v:
Dalton transactions (Cambridge, England : 2003) [Dalton Trans] 2024 Nov 04. Date of Electronic Publication: 2024 Nov 04.
Autor:
Hersh CM; Lou Ruvo Center for Brain Health, Cleveland Clinic, Las Vegas, NV, United States. Electronic address: hershc@ccf.org., Sun Z; Biogen, Cambridge, MA, United States., Conway DS; Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, United States., Sotirchos ES; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States., Fitzgerald KC; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, United States., Hua LH; Lou Ruvo Center for Brain Health, Cleveland Clinic, Las Vegas, NV, United States., Ziemssen T; Center of Clinical Neuroscience, Department of Neurology, University Clinic Carl-Gustav Carus, TU Dresden, Dresden, Germany., Naismith RT; Department of Neurology, Washington University, St. Louis, MO, United States., Pellegrini F; Biogen, Cambridge, MA, United States., Grossman C; Biogen, Cambridge, MA, United States., Campbell N; Biogen, Cambridge, MA, United States.
Publikováno v:
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2024 Nov; Vol. 91, pp. 105847. Date of Electronic Publication: 2024 Sep 02.
Autor:
Abbatemarco JR; Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH, USA., Aboseif A; Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH, USA.; Center for Multiple Sclerosis and Autoimmune Neurology, Department of Neurology, Mayo Clinic College of Medicine, Rochester, MN, USA., Swetlik C; Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH, USA., Widmar J; Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH, USA., Harvey T; Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH, USA., Kunchok A; Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH, USA., O'Mahony J; Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH, USA., Miller DM; Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH, USA., Conway DS; Mellen Center for Multiple Sclerosis, Cleveland Clinic Foundation, Cleveland, OH, USA.
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Sep; Vol. 30 (10), pp. 1322-1330. Date of Electronic Publication: 2024 Aug 06.
Longitudinal myelin content measures of slowly expanding lesions using 7T MRI in multiple sclerosis.
Autor:
Huerta MM; School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA., Conway DS; Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA., Planchon SM; Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA., Thoomukuntla B; Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio, USA., Se-Hong O; Department of Biomedical Engineering, Hankuk University of Foreign Studies, Yongin, Republic of Korea., Sakaie KE; Imaging Institute, Cleveland Clinic, Cleveland, Ohio, USA., Ontaneda D; Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA., Nakamura K; Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio, USA.
Publikováno v:
Journal of neuroimaging : official journal of the American Society of Neuroimaging [J Neuroimaging] 2024 Jul-Aug; Vol. 34 (4), pp. 451-458. Date of Electronic Publication: 2024 May 22.
Autor:
Marian LM; Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH, USA., Harris KA; Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH, USA., Conway DS; Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH, USA.
Publikováno v:
Multiple sclerosis journal - experimental, translational and clinical [Mult Scler J Exp Transl Clin] 2024 May 06; Vol. 10 (2), pp. 20552173241251707. Date of Electronic Publication: 2024 May 06 (Print Publication: 2024).
Autor:
Ross LA; From the Mellen Center for Multiple Sclerosis Treatment and Research (L.A.R., A.K.C., D.S.C., J.A.C., A.K.) and Diagnostic Radiology (J.L.), Cleveland Clinic, OH; Department of Neurosciences (J.G.), University of California San Diego, La Jolla, CA; UCSF Weill Institute of Neurosciences (S.S.Z.), University of California at San Francisco; and Department of Neurology (S.D.N.), Johns Hopkins School of Medicine, Baltimore, MD., Lee J; From the Mellen Center for Multiple Sclerosis Treatment and Research (L.A.R., A.K.C., D.S.C., J.A.C., A.K.) and Diagnostic Radiology (J.L.), Cleveland Clinic, OH; Department of Neurosciences (J.G.), University of California San Diego, La Jolla, CA; UCSF Weill Institute of Neurosciences (S.S.Z.), University of California at San Francisco; and Department of Neurology (S.D.N.), Johns Hopkins School of Medicine, Baltimore, MD., Carlson AK; From the Mellen Center for Multiple Sclerosis Treatment and Research (L.A.R., A.K.C., D.S.C., J.A.C., A.K.) and Diagnostic Radiology (J.L.), Cleveland Clinic, OH; Department of Neurosciences (J.G.), University of California San Diego, La Jolla, CA; UCSF Weill Institute of Neurosciences (S.S.Z.), University of California at San Francisco; and Department of Neurology (S.D.N.), Johns Hopkins School of Medicine, Baltimore, MD., Conway DS; From the Mellen Center for Multiple Sclerosis Treatment and Research (L.A.R., A.K.C., D.S.C., J.A.C., A.K.) and Diagnostic Radiology (J.L.), Cleveland Clinic, OH; Department of Neurosciences (J.G.), University of California San Diego, La Jolla, CA; UCSF Weill Institute of Neurosciences (S.S.Z.), University of California at San Francisco; and Department of Neurology (S.D.N.), Johns Hopkins School of Medicine, Baltimore, MD., Cohen JA; From the Mellen Center for Multiple Sclerosis Treatment and Research (L.A.R., A.K.C., D.S.C., J.A.C., A.K.) and Diagnostic Radiology (J.L.), Cleveland Clinic, OH; Department of Neurosciences (J.G.), University of California San Diego, La Jolla, CA; UCSF Weill Institute of Neurosciences (S.S.Z.), University of California at San Francisco; and Department of Neurology (S.D.N.), Johns Hopkins School of Medicine, Baltimore, MD., Graves J; From the Mellen Center for Multiple Sclerosis Treatment and Research (L.A.R., A.K.C., D.S.C., J.A.C., A.K.) and Diagnostic Radiology (J.L.), Cleveland Clinic, OH; Department of Neurosciences (J.G.), University of California San Diego, La Jolla, CA; UCSF Weill Institute of Neurosciences (S.S.Z.), University of California at San Francisco; and Department of Neurology (S.D.N.), Johns Hopkins School of Medicine, Baltimore, MD., Zamvil SS; From the Mellen Center for Multiple Sclerosis Treatment and Research (L.A.R., A.K.C., D.S.C., J.A.C., A.K.) and Diagnostic Radiology (J.L.), Cleveland Clinic, OH; Department of Neurosciences (J.G.), University of California San Diego, La Jolla, CA; UCSF Weill Institute of Neurosciences (S.S.Z.), University of California at San Francisco; and Department of Neurology (S.D.N.), Johns Hopkins School of Medicine, Baltimore, MD., Newsome SD; From the Mellen Center for Multiple Sclerosis Treatment and Research (L.A.R., A.K.C., D.S.C., J.A.C., A.K.) and Diagnostic Radiology (J.L.), Cleveland Clinic, OH; Department of Neurosciences (J.G.), University of California San Diego, La Jolla, CA; UCSF Weill Institute of Neurosciences (S.S.Z.), University of California at San Francisco; and Department of Neurology (S.D.N.), Johns Hopkins School of Medicine, Baltimore, MD., Kunchok A; From the Mellen Center for Multiple Sclerosis Treatment and Research (L.A.R., A.K.C., D.S.C., J.A.C., A.K.) and Diagnostic Radiology (J.L.), Cleveland Clinic, OH; Department of Neurosciences (J.G.), University of California San Diego, La Jolla, CA; UCSF Weill Institute of Neurosciences (S.S.Z.), University of California at San Francisco; and Department of Neurology (S.D.N.), Johns Hopkins School of Medicine, Baltimore, MD.
Publikováno v:
Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2024 May; Vol. 11 (3), pp. e200210. Date of Electronic Publication: 2024 Feb 22.
Autor:
Toljan K; Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue / U10, Cleveland, OH, 44195, USA., Conway DS; Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue / U10, Cleveland, OH, 44195, USA. Electronic address: conwayd2@ccf.org.
Publikováno v:
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2024 Apr; Vol. 21 (3), pp. e00351. Date of Electronic Publication: 2024 Mar 25.